0LER.IL - Teva Pharmaceutical Industries Limited

IOB - IOB Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 9.27B
Enterprise value 28.03B
Trailing P/E N/A
Forward P/E 3.27
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.59
Price/book (mrq)1.13
Enterprise value/revenue 1.88
Enterprise value/EBITDA -213.93

Trading information

Stock price history

Beta (5Y monthly) 1.19
52-week change 3-18.56%
S&P500 52-week change 31.77%
52-week high 311.33
52-week low 36.82
50-day moving average 38.50
200-day moving average 39.10

Share statistics

Avg vol (3-month) 330.46k
Avg vol (10-day) 313.94k
Shares outstanding 51.12B
Implied shares outstanding 6N/A
Float 81.11B
% held by insiders 10.00%
% held by institutions 151.06%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023


Profit margin -10.74%
Operating margin (ttm)16.72%

Management effectiveness

Return on assets (ttm)3.45%
Return on equity (ttm)-17.93%

Income statement

Revenue (ttm)14.92B
Revenue per share (ttm)13.42
Quarterly revenue growth (yoy)0.00%
Gross profit (ttm)6.97B
Net income avi to common (ttm)-1.6B
Diluted EPS (ttm)-1.39
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.14B
Total cash per share (mrq)1.91
Total debt (mrq)21.04B
Total debt/equity (mrq)244.29
Current ratio (mrq)1.11
Book value per share (mrq)7.01

Cash flow statement

Operating cash flow (ttm)1.49B
Levered free cash flow (ttm)2.62B